| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 6.71% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 5.41% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 4.07% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 3.75% |
| ARGX | ARGENX SE ADR | 3.54% |
| IONS | IONIS PHARMACEUTICALS INC | 3.47% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 3.37% |
| NTRA | NATERA INC | 3.29% |
| ALKS | ALKERMES INC | 2.69% |
| TARS | TARSUS PHARMACEUTICALS | 2.67% |
| NUVL | NUVALENT INC | 2.44% |
| MCK | MCKESSON CORP | 2.33% |
| HCA | HCA HOLDINGS INC | 2.20% |
| CYTK | CYTOKINETICS INC | 2.12% |
| LNTH | LANTHEUS HOLDINGS INC | 2.04% |
| AZN | ASTRAZENECA PLC | 2.02% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.89% |
| ISRG | INTUITIVE SURGICAL INC | 1.88% |
| LLY | ELI LILLY CORP | 1.72% |
| AMGN | AMGEN CORP | 1.72% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.71% |
| APLS | APELLIS PHARMACEUTICALS INC | 1.69% |
| IDXX | IDEXX LABS CORP | 1.69% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.66% |
| DNLI | DENALI THERAPEUTICS INC. | 1.61% |
| IMVT | IMMUNOVANT INC | 1.59% |
| EW | EDWARDS LIFESCIENCES CORP | 1.54% |
| SYK | STRYKER CORP | 1.51% |
| SNY | SANOFI- AVENTIS- ADR | 1.49% |
| MRK | MERCK & CO. NEW | 1.43% |
| BIIB | BIOGEN INC | 1.40% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.37% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.28% |
| REGN | REGENERON PHARMACEUTICALS | 1.26% |
| UNH | UNITEDHEALTH GROUP INC | 1.25% |
| ELV | ELEVANCE HEALTH INC | 1.25% |
| BSX | BOSTON SCIENTIFIC | 1.22% |
| PCVX | VAXCYTE INC | 1.22% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.16% |
| DYN | DYNE THERAPEUTICS, INC. | 1.13% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.10% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.09% |
| DHR | DANAHER CORP | 1.06% |
| BDX | BECTON DICKINSON & CO | 1.04% |
| XNCR | XENCOR INC. | 0.92% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.78% |
| DXCM | DEXCOM INC | 0.78% |
| KURA | KURA ONCOLOGY INC | 0.74% |
| ZTS | ZOETIS INC | 0.73% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.67% |
| NVO | NOVO NORDISK A/S | 0.60% |
| AVTR | AVANTOR, INC. | 0.55% |
| TNDM | TANDEM DIABETES CARE INC | 0.53% |
| ARVN | ARVINAS INC USD | 0.50% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.48% |
| WAT | WATERS CORP | 0.33% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.24% |
| RNA | ATRIUM THERAPEUTICS INC | 0.08% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.